Kevin Boyle Sr - Chief Executive Officer, Ziopharm Oncology Inc

As of November 17, 2021

Kevin Boyle Sr Net Worth

• Owns at least 885,000 units of Ziopharm Oncology Inc stock

Kevin Boyle Sr Trading

• Largest purchase of shares was 10,000 units , worth over $14K on November 17, 2021
• In total has made about 2 transactions over 3 months
• Usually trades in August and November, with the busiest year in 2021

Kevin Boyle Sr Mailing Address

• Mailing address is C/o Ziopharm Oncology, Inc. One First Avenue, Parris Bldg 34 Boston MA 02129 MA

Ziopharm Oncology Inc Insider Trading

• The most recent transaction was 20,132 units sold on December 27, 2021 by Eleanor de Groot worth over $25.57K
• In the last 14 years, insiders at Ziopharm Oncology Inc sold an estimated value of $13.56M and bought an estimated value of $76.75M
• The most active traders are Randal Kirk, Director,  Intrexon Corp,  and Anthony James Cannon, Director
• Insider trading is most common in January, with the busiest year in 2017